| Patient | Florence Nightingale |
|---|---|
| Date of birth | 1820-05-12 |
| Identifiers | MRN HR-NI004-SYN-TD; SSN (made up) 000-04-9271 |
| Document date | 1858-09-14 |
| Author | Isobel Marchetti, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-month ME/CFS care plan review. [S]
Ms. Nightingale returns for her six-month review. The extra half hour of work agreed in June held without post-exertional malaise, and she later added another half hour, so she now works four to five hours a day in 45-minute blocks with rests between. Her July cold caused a flare that settled in about ten days on her flare plan, with no fever afterward and no night sweats or back or joint pain. Since then she has had no crash. She goes out twice a week, for a short walk or a meeting, and plans a rest day after each outing. She is lightheaded on standing about twice a week. Sleep is still not fully refreshing, and acetaminophen is needed a few times a month. She takes cholecalciferol daily. [S]
| Element | Detail |
|---|---|
| Interval change | One flare after a cold in July; no crash since |
| Energy management | Four to five hours of work a day in 45-minute blocks |
| Function | Out of the house twice a week with a rest day after |
| Orthostatic symptoms | About twice a week |
| Infection warning signs | No fever, night sweats, or back or joint pain since the cold |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue at an improved baseline; no fever, night sweats, or weight loss |
| Cardiovascular | Positive | Lightheaded on standing about twice a week; no syncope |
| Musculoskeletal | Negative | No back, hip, or joint pain or swelling |
| Neurological | Positive | Word-finding difficulty only when tired |
| Psychiatric | Negative | Mood steady; PHQ-9 score 5 and GAD-7 score 4 |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a day | One to two tablets by mouth every 6 hours as needed; no more than 3 g a day | Oral route | 1857-11-03 | active | S |
| Cholecalciferol (vitamin D3) 50 mcg (2,000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1858-03-16 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1858-09-14 | Body height | 170 | cm | S |
| 1858-09-14 | Body weight | 56 | kg | S |
| 1858-09-14 | Body mass index (BMI) [Ratio] | 19.4 | kg/m2 | S |
| 1858-09-14 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1858-09-14 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1858-09-14 | Heart rate | 72 | /min | S |
| 1858-09-14 | Respiratory rate | 14 | /min | S |
| 1858-09-14 | Body temperature | 36.6 | Cel | S |
| 1858-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1858-09-14 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 34 | ng/mL | 30-100 ng/mL | Normal | S |
| 1858-09-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 1858-09-14 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 4 | {score} | S | ||
| 1858-09-14 | PROMIS fatigue - version 1.0 Tscore | 64 | {score} | S | ||
| 1858-09-14 | PROMIS physical function - version 1.0 Tscore | 38 | {score} | S | ||
| 1858-09-14 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S |
Vital signs recorded on 1858-09-14; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well and engaged throughout the visit |
| Cardiovascular | Regular rhythm; no murmur |
| Abdomen | No liver or spleen enlargement |
| Musculoskeletal | No spinal, sacroiliac, or joint tenderness |
| Orthostatic test | Ten-minute standing test: heart rate rise of 18/min, down from 26/min at intake; no hypotension; mild lightheadedness only after minute 8 |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFS | active | confirmed | G93.32 | S — Synthetic diagnosis made by clinical criteria after exclusion tests in the modern episode; the historical reading of her illness as ME/CFS remains R and disputed. |
| Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapse | active | confirmed | Z86.19 | S — Synthetic history echoing the disputed retrospective interpretation of her Crimean fever as brucellosis; not a historical diagnosis. |
| Vitamin D deficiency | active | confirmed | E55.9 | S — Synthetic finding on the intake tests, reviewed at the two-week visit. |
| Acute viral upper respiratory infection with a short ME/CFS flare, resolved without antibiotics | resolved | confirmed | J06.9 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | 25-hydroxyvitamin D after starting repletion | Once, about three months after starting | Completed today | 34 ng/mL, now replete; drawn today after it was missed at the three-month review |
| Survey | PHQ-9 and GAD-7 | At diagnosis and at each review | Completed today | PHQ-9 5 with item 9 scored 0; GAD-7 4 |
| Survey | PROMIS fatigue and physical function T-scores, pain score | At diagnosis and at each review | Completed today | Fatigue 64, physical function 38, pain 3 |
| Examination | Ten-minute standing test | Repeat at six months | Completed today | Heart rate rise of 18/min, down from 26/min |
| Examination | Symptom review, including infection warning signs | Every review | Completed today | No crash since the July flare; no fever, night sweats, or focal pain |
| Self-management | Energy management and flare plan review | Every review | Completed today | Flare plan worked as intended during the July cold |
| Medication safety | Medication review | Every review | Completed today | Cholecalciferol daily; acetaminophen a few times a month |
| Referral | ME/CFS specialist team | At diagnosis (NICE 1.4.3) | Deferred | Still no regional service; care continues in primary care with the occupational therapist available as needed |
Goal progress:
Guideline basis: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024); Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023)
Follow-up: Adult preventive visit next month. ME/CFS review in about three months, then at least yearly. Next scheduled visit 1858-10-12: adult preventive visit. [S]